BOVESPA:FLRY3 수익, 비용 및 수입 (BRL Millions )
날짜	수익	수익	G+A 비용
31 Mar 24	7,138	498	888
31 Dec 23	6,471	424	827
30 Sep 23	5,881	373	751
30 Jun 23	5,158	295	661
31 Mar 23	4,610	291	530
31 Dec 22	4,463	308	498
30 Sep 22	4,366	348	534
30 Jun 22	4,248	347	551
31 Mar 22	4,069	342	514
31 Dec 21	3,873	350	481
30 Sep 21	3,783	419	399
30 Jun 21	3,629	456	335
31 Mar 21	3,151	317	316
31 Dec 20	2,972	257	321
30 Sep 20	2,764	174	309
30 Jun 20	2,645	133	325
31 Mar 20	2,918	278	330
31 Dec 19	2,905	312	320
30 Sep 19	2,840	314	314
30 Jun 19	2,767	314	296
31 Mar 19	2,712	328	297
31 Dec 18	2,664	332	296
30 Sep 18	2,592	338	281
30 Jun 18	2,524	334	275
31 Mar 18	2,449	335	267
31 Dec 17	2,383	321	257
30 Sep 17	2,324	331	260
30 Jun 17	2,248	307	257
31 Mar 17	2,176	266	249
31 Dec 16	2,096	229	243
30 Sep 16	2,046	180	233
30 Jun 16	2,002	152	229
31 Mar 16	1,956	139	224
31 Dec 15	1,895	107	222
30 Sep 15	1,845	94	224
30 Jun 15	1,801	90	216
31 Mar 15	1,730	73	209
31 Dec 14	1,679	86	209
30 Sep 14	1,646	73	206
30 Jun 14	1,634	60	215
31 Mar 14	1,659	66	223
31 Dec 13	1,657	61	216
30 Sep 13	1,643	78	211
30 Jun 13	1,603	86	211

양질의 수익: FLRY3 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: FLRY3 의 현재 순이익 이익률 (7%) 작년보다 높습니다 (6.3%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: FLRY3 의 수입은 지난 5년 동안 매년 7.8% 씩 증가했습니다.

성장 가속화: 지난 1년간 FLRY3 의 수익 증가율( 70.9% )은 연간 평균( 7.8% 초과합니다. ).

수익 대 산업: 지난 1년간 FLRY3 수익 증가율( 70.9% )은 Healthcare 업계 63.3% 초과했습니다.

Fleury 과거 수익 실적

과거 기준 확인 5/6

주요 정보

최근 과거 실적 업데이트

First quarter 2024 earnings released

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Fleury S.A. to Report Q3, 2024 Results on Nov 07, 2024

Third quarter 2023 earnings: Revenues in line with analyst expectations

Second quarter 2023 earnings: Revenues in line with analyst expectations

Recent updates

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

First quarter 2024 earnings released

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Upcoming dividend of R$0.15 per share

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 22% undervalued after recent price drop

Fleury S.A. to Report Q3, 2024 Results on Nov 07, 2024

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Consensus EPS estimates increase by 10%, revenue downgraded

Third quarter 2023 earnings: Revenues in line with analyst expectations

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Second quarter 2023 earnings: Revenues in line with analyst expectations

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

New major risk - Shareholder dilution

Fleury S.A. to Report Q3, 2023 Results on Nov 09, 2023

First quarter 2023 earnings: Revenues exceed analyst expectations

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Less than half of directors are independent

Consensus forecasts updated

Consensus forecasts updated

Third quarter 2022 earnings: Revenues exceed analyst expectations

Fleury S.A. (BOVESPA:FLRY3) completed the acquisition of Methodos laboratory in Minas Gerais.

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: Revenues exceed analyst expectations

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Investor sentiment improved over the past week

Less than half of directors are independent

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

First quarter 2022 earnings: Revenues exceed analyst expectations

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Now 24% undervalued after recent price drop

Consensus forecasts updated

Price target decreased to R$20.75

Now 22% undervalued after recent price drop

Fleury S.A. to Report Fiscal Year 2021 Results on Mar 17, 2022

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Now 20% undervalued after recent price drop

High number of new directors

Price target decreased to R$23.18

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Price target decreased to R$26.38

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Second quarter 2021 earnings released

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Consensus EPS estimates increase to R$1.19

First quarter 2021 earnings released

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Analysts update estimates

New 90-day low: R$25.63

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Revenue and earnings beat expectations

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Full year 2020 earnings released

Fleury S.A. to Report Q4, 2020 Results on Feb 25, 2021

What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?

Analysts increase EPS estimates to R$0.61

Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return